2024 UK and Ireland modified Delphi consensus on myopia management in children and young people.
Saved in:
| Title: | 2024 UK and Ireland modified Delphi consensus on myopia management in children and young people. |
|---|---|
| Authors: | Dahlmann‐Noor, Annegret H. (AUTHOR), Ghorbani‐Mojarrad, Neema (AUTHOR), Williams, Katie M. (AUTHOR), Ghoneim, Ahmed (AUTHOR), Allen, Peter M. (AUTHOR), Beach, Michelle L. (AUTHOR), Bruce, Gillian (AUTHOR), Buckhurst, Hetal D. (AUTHOR), Buckhurst, Phillip J. (AUTHOR), Cruickshank, Fiona E. (AUTHOR), Cufflin, Matthew P. (AUTHOR), Day, Mhairi D. (AUTHOR), Doyle, Lesley (AUTHOR), Evans, Bruce J. W. (AUTHOR), Flitcroft, Daniel Ian (AUTHOR), Gray, Lyle S. (AUTHOR), Grewal, Indie (AUTHOR), Guggenheim, Jeremy A. (AUTHOR), Hammond, Christopher J. (AUTHOR), Higginbotham, Jason C. (AUTHOR) |
| Source: | Ophthalmic & Physiological Optics. Nov2024, Vol. 44 Issue 7, p1368-1391. 24p. |
| Subjects: | Young adults, Delphi method, Eye care, Myopia, Visual training |
| Abstract: | Introduction: This work aimed to establish the largest UK and Ireland consensus on myopia management in children and young people (CYP). Methods: A modified Delphi consensus was conducted with a panel of 34 optometrists and ophthalmologists with expertise in myopia management. Results: Two rounds of voting took place and 131 statements were agreed, including that interventions should be discussed with parents/carers of all CYP who develop myopia before the age of 13 years, a recommendation for interventions to be publicly funded for those at risk of fast progression and high myopia, that intervention selection should take into account the CYP's hobbies and lifestyle and that additional training for eye care professionals should be available from non‐commercial sources. Topics for which published evidence is limited or lacking were areas of weaker or no consensus. Modern myopia management contact and spectacles are suitable first‐line treatments. The role and provision of low‐concentration atropine needs to be reviewed once marketing authorisations and funding decisions are in place. There is some evidence that a combination of low‐concentration atropine with an optical intervention can have an additive effect; further research is needed. Once an intervention is started, best practice is to monitor non‐cycloplegic axial length 6 monthly. Conclusion: Research is needed to identify those at risk of progression, the long‐term effectiveness of individual and combined interventions, and when to discontinue treatment when myopia has stabilised. As further evidence continues to emerge, this consensus work will be repeated to ensure it remains relevant. [ABSTRACT FROM AUTHOR] |
| Copyright of Ophthalmic & Physiological Optics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Introduction: This work aimed to establish the largest UK and Ireland consensus on myopia management in children and young people (CYP). Methods: A modified Delphi consensus was conducted with a panel of 34 optometrists and ophthalmologists with expertise in myopia management. Results: Two rounds of voting took place and 131 statements were agreed, including that interventions should be discussed with parents/carers of all CYP who develop myopia before the age of 13 years, a recommendation for interventions to be publicly funded for those at risk of fast progression and high myopia, that intervention selection should take into account the CYP's hobbies and lifestyle and that additional training for eye care professionals should be available from non‐commercial sources. Topics for which published evidence is limited or lacking were areas of weaker or no consensus. Modern myopia management contact and spectacles are suitable first‐line treatments. The role and provision of low‐concentration atropine needs to be reviewed once marketing authorisations and funding decisions are in place. There is some evidence that a combination of low‐concentration atropine with an optical intervention can have an additive effect; further research is needed. Once an intervention is started, best practice is to monitor non‐cycloplegic axial length 6 monthly. Conclusion: Research is needed to identify those at risk of progression, the long‐term effectiveness of individual and combined interventions, and when to discontinue treatment when myopia has stabilised. As further evidence continues to emerge, this consensus work will be repeated to ensure it remains relevant. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 02755408 |
| DOI: | 10.1111/opo.13381 |
